Prostate News Archive
21-May-2008
New analysis boosts drug's prostate cancer value (Reuters via Yahoo! News)
A new analysis of data from a key prostate cancer study has strengthened the view that a drug that is now sold as a generic may be a valuable weapon to prevent prostate cancer, researchers said on Monday. Radiation Improves Survival for Advanced Prostate Cancer (HealthCentral.com)
Copyright © 2008 ScoutNews LLC. All rights reserved. TUESDAY, May 20 (HealthDay News) -- Men with advanced prostate cancer that hasn't spread beyond the gland should receive radiation therapy as soon as the prostate has been removed, a new long-term study says. New analysis finds benefit from drug for prostate cancer (Philly.com)
The latest analyses from a federal study of the drug finasteride is good news for men interested in using it to reduce the risk of prostate cancer. The pill reduced the development of prostate cancer by 25 percent. Imaging helps diagnose prostate cancer (UPI)
LEESBURG, Va., May 20 (UPI) -- Dynamic contrast-enhanced magnetic resonance imaging plus diffusion weighted imaging can diagnose recurrent prostate cancer, a U.S. researchers says. Aureon launches new prostate cancer diagnostic test (Pharmaceutical Business Review)
Aureon Laboratories has introduced new prostate Px+, the first commercial test said to predict prostate cancer progression and disease recurrence at the time of diagnosis.
Back to Prostate News Archive
